The Sounds of Silence

Science-based tinnitus therapeutics are finally coming into their own.

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

STOP THE RINGING: Tinnitus can manifest early in auditory perception, as damage to the inner ear, or in the brain where sounds are processed. Researchers developing treatments for the condition are targeting various points along this pathway.
See full infographic: JPG
© MARI SCHMITT/SCIENCE SOURCE; © ENCYCLOPEDIA BRITANNICA/UIG/GETTY IMAGES
It often starts off with a bang. Many a soldier, construction worker, concertgoer, or innocent passerby exposed to a loud noise walks away with the telltale symptom of tinnitus, a persistent ringing in the ears. The condition can also arise from other ear traumas, such as middle-ear infections or exposure to high pressure while scuba diving, and begins with damage to the hair cells in the cochlea of the inner ear or to the auditory nerve. Until recently, such damage was thought to be the cause of the phantom sounds that plague tinnitus sufferers. Now, researchers are realizing that it’s much more complex than that.

“Damage to hair cells and auditory nerve fibers sets the stage for the development of tinnitus,” says Jennifer Melcher of the Massachusetts Eye and Ear Infirmary. But the true culprit is really the brain, which eventually begins to compensate for the loss of input from the ear by “turning up the volume” on the sound signals it is trying to pick up, she adds. Navzer Engineer, chief scientific officer of Dallas-based MicroTransponder, which is developing a neurostimulative treatment for tinnitus, agrees: “Cells in the brain don’t stay dormant” even though they have lost input from the ear, he says.

It’s unclear when the condition transitions from the ear to the brain. Researchers also do not yet know whether the brain or peripheral nerves are primarily ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jenny Rood

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours